Publication
Road to COP29: Our insights
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Thought leadership and insights for businesses
Businesses continually evolve – geographical expansion, the introduction of new technology, or the constant challenge of regulatory compliance can make it difficult for businesses to stay a step ahead and be prepared for disputes or litigation issues that may arise.
To keep clients up to date on the latest trends and developments, we have created a Disputes hub as part of our NRF Institute, consolidating publications and insights from our global dispute resolution and litigation team with related updates and products.
Topics include
- Banking and finance disputes
- Corporate and commercial disputes
- International arbitration
- Legal privilege
- Regulatory, compliance and investigations
- Sanctions
Register for the hub
To request access to the ‘Dispute hub’, please register to join NRF Institute.
Registration indicates acceptance of the terms and conditions which include important information about how our product will be delivered.
Members of NRF Institute can access a range of premium content including knowledge hubs and cross-border guides.
Head of Disputes Knowledge, Innovation and Business Support, Europe, Middle East and Asia
Email
adam.sanitt@nortonrosefulbright.com
Recent publications
Publication
Country risk in unprecedented times: A precedent for cross-border loan documentation?
While country risk cannot be avoided in cross-border transactions entirely, it can be effectively mitigated through careful transaction structuring and tailored contractual protections.
Publication
The GCR Guide to Life Sciences – Merger control: Procedural issues
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .